Ann: Trading Halt, page-184

First 184 Last

Share
Profile

Follow
PieChart

3,697 Posts.

766

03/02/23

07:24

Post #: 66044621
Share

Originally posted by FreeflyerNZ: ↑

Its a nice story wenty but in regards to CYM most holders such as myself who researched and bought continuously over the last two years are significantly down.

At some point the stock was over 80% down from its high. Add to that we have been diluted a couple times at very low prices and have been dragged through the mud with false promises around finance. Suggested Christmas 21, and mining by the end of 2022.

CYM would be lucky reach 0.36 which would be a 230% rise from 11c and a market cap of just under 400m. Roughly of course.

CXO will have a rapid pay back and earning more free cash flow in a month then CYM will earn in a year. There's your difference.

I noticed you are a bit more positive but you also haven't suffered the pain us long termers have over the last couple years. The loss of investment and opportunity cost has been significant for me and no doubt many others.

when you take into considering debt, and FCF. While I'm expecting good gains I really don't see how you see this rerating 10x like CXO.

I think we will see significant gains but it's going to take a much longer time to get there.

Expand

He also failed to mention that virtually every battery metal stock did a 10x in that period. I remember some names in here who participated in the nvx raise at 29c, EGR, RNU, QPM, ASM, IXR, and the list goes on of battery metal stocks which multi bagged.

And with the price of lithium exploding lithium stocks did even better then the other BM stocks. Copper will have its day but it's still awhile away.

Last edited by PieChart: 03/02/23

CYM Price at posting: 13.5¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

IRE

Iress runs 'hot' for Wealth Within's stock tips

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Failure to report prompts ASX to impose multiple company suspensions

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 51 more messages in this thread...

First 184 Last

Add CYM (ASX) to my watchlist

(20min delay)
Last 3.7¢		Change 0.000(0.00%)		Mkt cap ! $56.46M

Open	High	Low	Value	Volume
3.7¢	3.7¢	3.5¢	$29.91K	825.3K

Buyers (Bids)

No.	Vol.	Price($)
3	77732	3.5¢

Sellers (Offers)

Price($)	Vol.	No.
3.7¢	170421	3

View Market Depth

No.	Vol.	Price($)
3	77732	0.035
3	318409	0.033
3	1343780	0.032
1	5000	0.031
4	333300	0.030

Price($)	Vol.	No.
0.037	170421	3
0.038	721845	3
0.039	640000	2
0.040	451062	2
0.041	377200	2

Last trade - 16.10pm 01/10/2024 (20 minute delay)

CYM (ASX) Chart

Ann: Trading Halt, page-184

Iress runs 'hot' for Wealth Within's stock tips

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Failure to report prompts ASX to impose multiple company suspensions

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Trading Halt, page-184

Top Stories

Iress runs 'hot' for Wealth Within's stock tips

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Failure to report prompts ASX to impose multiple company suspensions

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News